Cetus Hospital Dia Oncologia

Belo Horizonte, Minas Gerais 30150-270

0 studies enrolling now · 4 studies all time

What they study most

Gastric Cancer, Gastroesophageal Junction Cancer, Muscle-invasive Bladder Cancer, Non-Small Cell Lung Cancer, Urothelial Carcinoma

Studies at this site

• A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Participants With High-risk Muscle-invasive Bladder Cancer (MIBC) Who Are ctDNA Positive Following Cystectomy — Running, not enrolling
• Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC — Running, not enrolling
• Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma — Completed
• A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer — Completed